208 related articles for article (PubMed ID: 16078921)
1. Sequestration of anti-Cra in the placenta: serologic demonstration by placental elution.
Weber SL; Bryant BJ; Indrikovs AJ
Transfusion; 2005 Aug; 45(8):1327-30. PubMed ID: 16078921
[TBL] [Abstract][Full Text] [Related]
2. Persistent anti-Dra in two pregnancies.
Rahimi-Levene N; Kornberg A; Siegel G; Morozov V; Shinar E; Asher O; Levene C; Yahalom V
Immunohematology; 2005; 21(3):126-8. PubMed ID: 16178671
[TBL] [Abstract][Full Text] [Related]
3. Disappearance of antibodies to Cromer blood group system antigens during mid pregnancy.
Reid ME; Chandrasekaran V; Sausais L; Pierre J; Bullock R
Vox Sang; 1996; 71(1):48-50. PubMed ID: 8837357
[TBL] [Abstract][Full Text] [Related]
4. Preferential expression of the complement regulatory protein decay accelerating factor at the fetomaternal interface during human pregnancy.
Holmes CH; Simpson KL; Wainwright SD; Tate CG; Houlihan JM; Sawyer IH; Rogers IP; Spring FA; Anstee DJ; Tanner MJ
J Immunol; 1990 Apr; 144(8):3099-105. PubMed ID: 1691227
[TBL] [Abstract][Full Text] [Related]
5. The Cromer blood group system: a review.
Storry JR; Reid ME; Yazer MH
Immunohematology; 2010; 26(3):109-18. PubMed ID: 21214297
[TBL] [Abstract][Full Text] [Related]
6. [Hemolytic disease of the newborn caused by maternal anti-Di(a): a case report in Taiwan].
Yung CH; Lin JS; Hu HY; Lyou JY; Chen YR; Chen CR; Hao TC; Peng CS; Tzeng CH
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1995 May; 28(2):146-50. PubMed ID: 9774993
[TBL] [Abstract][Full Text] [Related]
7. Evidence for allergen-specific IgE of maternal origin in human placenta.
Joerink M; Rindsjö E; Stenius F; Alm J; Lilja G; Grönlund H; Scheynius A
Allergy; 2009 Jun; 64(6):905-12. PubMed ID: 19220215
[TBL] [Abstract][Full Text] [Related]
8. Hemolytic disease of the fetus and newborn caused by an antibody to a low-prevalence antigen, anti-SARA.
Towns D; Hannon J; Hendry J; Barnes J; Goldman M
Transfusion; 2011 Sep; 51(9):1977-9. PubMed ID: 21414007
[TBL] [Abstract][Full Text] [Related]
9. A case of hemolytic disease of the newborn due to anti-Dib antibodies.
Uchikawa M; Shibata Y; Tohyama H; Mori H; Aisaka K; Nakagawa M
Vox Sang; 1982 Feb; 42(2):91-2. PubMed ID: 7199783
[TBL] [Abstract][Full Text] [Related]
10. Clinically significant hemolytic disease of the newborn secondary to passive transfer of anti-D from maternal RhIG.
Cohen DN; Johnson MS; Liang WH; McDaniel HL; Young PP
Transfusion; 2014 Nov; 54(11):2863-6. PubMed ID: 24826985
[TBL] [Abstract][Full Text] [Related]
11. Blocking of fetal K antigens on cord red blood cells by maternal anti-K.
Lee E; Redman M; Owen I
Transfus Med; 2009 Jun; 19(3):139-40. PubMed ID: 19566671
[TBL] [Abstract][Full Text] [Related]
12. Hemagglutination inhibition of Cromer blood group antibodies with soluble recombinant decay-accelerating factor.
Daniels GL; Green CA; Powell RM; Ward T
Transfusion; 1998 Apr; 38(4):332-6. PubMed ID: 9595014
[TBL] [Abstract][Full Text] [Related]
13. Fatal hemolytic disease of the fetus and newborn associated with anti-Jr.
Peyrard T; Pham BN; Arnaud L; Fleutiaux S; Brossard Y; Guerin B; Desmoulins I; Rouger P; Le Pennec PY
Transfusion; 2008 Sep; 48(9):1906-11. PubMed ID: 18522708
[TBL] [Abstract][Full Text] [Related]
14. Three new high-prevalence antigens in the Cromer blood group system.
Hue-Roye K; Lomas-Francis C; Belaygorod L; Lublin DM; Barnes J; Chung A; Fung-Kee-Fung K; Kinney J; Goldman-Lavi R; Yahalom V; Poole J; Ivankovic Z; Alcantara D; Bekavac M; Cepulic BG; Velliquette RW; Mason R; Reid ME
Transfusion; 2007 Sep; 47(9):1621-9. PubMed ID: 17725726
[TBL] [Abstract][Full Text] [Related]
15. Fetomaternal hemorrhage following funipuncture: increase in severity of maternal red-cell alloimmunization.
Bowman JM; Pollock JM; Peterson LE; Harman CR; Manning FA; Menticoglou SM
Obstet Gynecol; 1994 Nov; 84(5):839-43. PubMed ID: 7936523
[TBL] [Abstract][Full Text] [Related]
16. Imbalance of mononuclear cell infiltrates in the placental tissue from foetuses after spontaneous abortion versus therapeutic termination from 8th to 12th weeks of gestational age.
Lambropoulou M; Tamiolakis D; Venizelos J; Liberis V; Galazios G; Tsikouras P; Karamanidis D; Petrakis G; Constantinidis T; Menegaki M; Papadopoulos N
Clin Exp Med; 2006 Dec; 6(4):171-6. PubMed ID: 17191109
[TBL] [Abstract][Full Text] [Related]
17. Late onset neonatal anaemia due to maternal anti-Ge: possible association with destruction of eythroid progenitors.
Arndt PA; Garratty G; Daniels G; Green CA; Wilkes AM; Hunt P; Do J; Glenn S; Peterson D
Transfus Med; 2005 Apr; 15(2):125-32. PubMed ID: 15859979
[TBL] [Abstract][Full Text] [Related]
18. [Clinical significance of anti-D IgG screening and titer detection in 286 RhD negative pregnant women].
Liu KL; Li N; Li BJ; Peng JY; Shu XW; Yu YY
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Mar; 11(3):185-7. PubMed ID: 19292952
[TBL] [Abstract][Full Text] [Related]
19. A challenging case of pregnancy with placenta accreta and very rare irregular antibodies versus Cromer blood group system: a case report.
Busani S; Ghirardini A; Petrella E; Neri I; Casari F; Venturelli D; De Santis M; Montagnani G; Facchinetti F; Girardis M
J Med Case Rep; 2015 May; 9():112. PubMed ID: 25975935
[TBL] [Abstract][Full Text] [Related]
20. Role for serial prenatal anti-Vel quantitative serologic monitoring with 2-ME serum treatment during pregnancy: case report.
Linz WJ; Fueger JT; Allen S; Johnson ST
Immunohematology; 2010; 26(1):8-10. PubMed ID: 20795312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
